郭建民

This profile gathers the share dealings of 郭建民 in 东北制药, where the filings describe the role as board member. Over a trading history stretching from 29 November 2021 to 15 October 2026, the count stands at 9 filings.

The open-market side counts 3 purchases for €136k alongside 6 sales for €122k. Taken together, the purchases exceed the sales by €14k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings no purchases and 6 sales.

Half of the purchases are above €36k and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +21.5%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 15 October 2026 with an open-market sale (€3,200) in 东北制药. The clock since the last published purchase (15 December 2021) now reads 1,789 days. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.